American Healthcare REIT
AHR · Health Care REITs
$53.02
0.7%Healthcare Realty Trust
HR · Health Care REITs
$17.95
0.1%The short version
- American Healthcare REIT is the larger business, with $2.3B of revenue in fiscal 2025 against $1.2B for Healthcare Realty Trust, about 1.9 times as much.
- American Healthcare REIT grew revenue faster (9.2%, against −6.9%).
| Latest fiscal year | AHR · FY25 | HR · FY25 |
|---|---|---|
| Size | ||
| Market cap | $10.2B | $6.1B |
| Revenue | $2.3B | $1.2B |
| Free cash flow | — | $127M |
| Net income | $69.8M | −$246M |
| Growth | ||
| Revenue growth | 9.2% | −6.9% |
| 5-year growth | 16.2% | 18.8% |
| Share count change | 27.7% | −4.3% |
| Profitability | ||
| Gross margin | 20.6% | — |
| Operating margin | 18.4% | — |
| Net margin | 3.1% | −20.8% |
| FCF margin | — | 10.8% |
| Return on capital | — | — |
| Return on equity | 2.5% | −5.0% |
| Balance sheet | ||
| Net debt | — | $4.0B |
| Net debt / EBITDA | — | — |
| Dividends and buybacks | $164M | $391M |
| Valuation & quality | ||
| P/E | 78.0x | — |
| Piotroski F-score | — | — |
FY16
AHR $3.2M
HR $461M
FY17
AHR $33.3M
HR $614M
FY18
AHR $84.5M
HR $696M
FY19
AHR $121M
HR $692M
FY20
AHR $1.1B
HR $500M
FY21
AHR $1.1B
HR $535M
FY22
AHR $1.4B
HR $933M
FY23
AHR $1.9B
HR $1.3B
FY24
AHR $2.1B
HR $1.3B
FY25
AHR $2.3B
HR $1.2B
AHR
HR
FY16
AHR −157.2%
HR 22.1%
FY17
AHR —
HR 20.1%
FY18
AHR —
HR —
FY19
AHR 183.3%
HR —
FY20
AHR 20.4%
HR —
FY21
AHR 19.0%
HR —
FY22
AHR 21.4%
HR —
FY23
AHR 16.4%
HR —
FY24
AHR 17.6%
HR —
FY25
AHR 18.4%
HR —
AHR
HR
FY16
AHR −$3.6M
HR $161M
FY17
AHR $11.3M
HR $243M
FY18
AHR $11.2M
HR $260M
FY19
AHR $111M
HR $249M
FY20
AHR $211M
HR $395M
FY21
AHR —
HR $135M
FY22
AHR $140M
HR $109M
FY23
AHR —
HR $269M
FY24
AHR —
HR $253M
FY25
AHR —
HR $127M
AHR
HR
FY16
AHR —
HR 2.5%
FY17
AHR —
HR 2.0%
FY18
AHR —
HR —
FY19
AHR —
HR —
FY20
AHR —
HR —
FY21
AHR —
HR —
FY22
AHR —
HR —
FY23
AHR —
HR —
FY24
AHR —
HR —
FY25
AHR —
HR —
AHR
HR
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.